Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VOGLIBOSE vs VONOPRAZAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VOGLIBOSE vs VONOPRAZAN: Safety Overview

Metric VOGLIBOSE VONOPRAZAN
Total FAERS Reports 238 2,019
Deaths Reported 27 73
Death Rate 11.3% 3.6%
Hospitalizations 139 342
Average Patient Age 70.2 yrs 63.6 yrs
% Female Patients 50.0% 65.3%
FDA Approval Date N/A Nov 1, 2023
Manufacturer N/A Phathom Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Prescription